InVitria® Introduces Optibumin® 25: The First 25% Animal-Free Recombinant Human Serum Albumin for Cell & Gene Therapy Manufacturing Junction City, KS – February 20, 2025 – InVitria, a leading provider of recombinant, chemically defined biomanufacturing and formulation components, today announced the launch of Optibumin 25, the first and only recombinant human serum albumin (rHSA) available …
Reading time: 6 minutes Share this article: Optimizing Cryopreservation with Animal-Origin-Free HSA Solutions Struggling with cell viability after thawing? You’re not alone. Cryopreservation plays a crucial role in biomanufacturing, especially in developing cell-based therapies, where post-thaw viability can impact everything from functionality to clinical success. Traditionally, dimethyl sulfoxide (DMSO) has been the go-to cryoprotectant, …
Key Points Optibumin®, InVitria’s high-purity recombinant human albumin, improves viable T cell retention during downstream washing. Optibumin performs comparably to clinical serum-derived HSA in this application, enabling a like-kind replacement. Optibumin is animal origin free, offering safety and regulatory advantages. Introduction Critical Role of Albumin in Cell Washing for Cell Therapy Cell washing occurs at …
